Live prices paused — reconnecting…
Moderna mRNA cancer vaccine FDA approved?
Loading...
Market trust
Review trustProviderManual ReviewEvidenceNot ReadyManual source - last checked Not checked yet
Market trust
Review trustProviderManual ReviewEvidenceNot ReadyManual source - last checked Not checked yet
- Trust score
- In review
- Source type
- Manual
- Provider health
- Manual Review
- Criteria quality
- Warn
- Market data quality
- Review
- Public evidence state
- Not Ready
- Chart data provenance
- Drazill Market Data
- Price history freshness
- Fresh
- Last source check
- Not checked yet
Trust methodology
Formula: market-trust-v1.0
Window: Latest market, criteria, provider, and evidence records
Confidence: MEDIUM
Informational only, not trading advice.
- - Provider health is market-specific when resolution checks exist and otherwise inferred from configuration.
- - Manual-only markets rely on admin review rather than automated source polling.
19%
Yes
@ $0.19
81%
No
@ $0.81
Market open
May 7, 2026, 06:41 p.m.
Market closes
Feb 24, 2027, 06:41 p.m.
Projected payout
After market closes
About This Market
By end of 2026, full approval not EUA. Resolves YES if the FDA grants approval (not just EUA) to any Moderna mRNA cancer vaccine before Jan 1, 2027. Source: FDA approval letters
Source
Official announcement or authoritative source
